Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The Philadelphia Tribune’s article on ChenMed highlighted a study published in the September issue of The American Journal of Managed Care® (AJMC®). The study, “High-Touch Care Leads to Better Outcomes and Lower Costs in a Senior Population,” evaluated the impact of a high-touch primary care model among a Medicare Advantage population in comparison with a standard practice—based model and found that the high-touch model improved healthcare utilization and reduced healthcare costs.
An article from Seeking Alpha mentioned the AJMC® published study “A Payer—Provider Partnership for Integrated Care of Patients Receiving Dialysis.” The study concluded that promising trends were observed among members participating in a payer—provider care partnership with respect to both clinical and economic outcomes.
The AJMC® article “Review Finds Mixed Results for APMs and New Care Delivery Models in Cancer” was included in OBR Oncology’s Monday newsfeed. The article covered a review that found limited evidence available to evaluate the efficacy of alternative payment and care models in cancer care.
The National Pharmaceutical Council (NPC)’s Monday CER Daily Newsfeed mentioned an article from AJMC®’s The Center for Biosimilars®. The article, “UK Health System Wins the Right to Treat AMD With Bevacizumab,” reported that the United Kingdom had ruled in favor of the National Health Service, allowing the health system to provide intravitreal injections of the anti—vascular endothelial growth factor agent bevacizumab to patients with age-related macular degeneration.
NPC's Thursday CER Daily Newsfeed also included an article from The Center for Biosimilars®. “With Payers Under Pressure, Biosimilars Must Demonstrate Their Value” covered a session from the SMi 9th annual conference on Biosimilars and Biobetters that discussed payers facing heightened pressure to lower costs in order to afford innovative therapies.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More